 Işılay Öztürk
M.Sc. (Ph.D) in Physical Chemistry in 2016 (2022), currently Post-doctoral researcher in Computational Biophysics. Her main research topic is the investigation of radiopharmaceutical compounds. Her interests include i) DFT calculations and benchmarking ii) investigating molecular, electronic properties and non-bonded interactions iii) data collection for molecular design.
[Email]
[ORCID profile]
|
 Ke Zuo
Ke Zuo got his bachelor’s degree in Pharmaceutical Engineering in 2015 and master’s degree in Medicinal Chemistry in 2018 at Chengdu University, China. He received his European Joint Ph.D. in computational biophysics at the RWTH Aachen University, Germany, the Hebrew University of Jerusalem, Israel, and the University of Ferrara, Italy, in 2023, under the supervision of Paolo Carloni, Rachel Nechushtai, and Fabio Schifano. The same year, he joined the University of
Cagliari as a postdoctoral researcher. His work focuses on the molecular simulation of protein-protein interaction networks in autism spectrum disorder.
[Email]
[ORCID profile]
|
 Alessio Atzori.
M.Sc. in Pharmaceutical Chemistry and Technologies at the University of Cagliari, Ph.D. in molecular modeling at the University of Manchester. Expertise in molecular mechanics methods applied to the elucidation of both plasticity and druggability of biological systems ranging from cancer regulation to multidrug efflux in bacteria. Currently employed as Technical Expert in Comput. Chemistry at Syngenta (UK).
[Email][Google Scholar]
|
 Venkata Krishnan Ramaswamy.
M.S.(Pharm.) in Pharmacoinformatics in 2013, Ph.D. in Physics in 2017 at University of Cagliari. My experience and expertise include the computational study of protein dynamics and protein-ligand interactions for applications in drug design. I have also developed a few cheminformatics software tools and contributed to the development of the MPDS software toolset. Currently computational Chemistry Developer at Cresset software & discovery services (UK).
[Email][Google Scholar] [ORCID profile]
|
 Francesca Cardamone.
MSc in Bioinformatics in 2014 at the University of Rome Tor Vergata (IT). PhD label in Materials for Health, Environment and Energy, Chemistry Department, in collaboration with Groningen University (NL). Post-Doctoral Researcher in 2019 at the Physics Department, University of Cagliari (IT). My research focuses on structural biology and dynamics of macromolecules in solution as well as protein-protein interactions, flow transports and mutants analysis associated with rare pathologies using several computational approaches. Expertise in AA-MD simulation and molecular docking methods.
[Google Scholar]
|
 Francesco Oliva.
Ph.D. in Industrial Chemistry in 2020. Developer of algorithms to automate the study of proteins related to neurological diseases and the impact of single point mutations on protein-protein interactions. Currently employed at EVOTEC, Toulouse (France).
[Google Scholar] [ORCID profile]
|
 Andrea Basciu, Post-Doctoral Researcher.
M.Sc. in Physics in 2016, Ph.D. in Physics in 2020, currently Post-Doctoral Researcher in Computational Biophysics, Physics Department,
University of Cagliari. His main research topics include: (i) studying molecular recognition events by means of enhanced-sampling MD simulations, machine learning algorithms and docking calculations; (ii) the setting-up of a database of protein conformations for drug-design applications; (iii) studying the structural assembly and the functioning of bacterial multidrug efflux transporters.
[Email] [Google Scholar] [ORCID profile]
|
 Andrea Catte, Post-Doctoral Researcher.
M.Sc. in Chemistry in 2000, Ph.D. in Chemistry in 2003, currently Post-Doctoral
Researcher in Computational Biophysics, Physics Department, University of Cagliari. His main research topic is the study of the interaction of RND transporters of Gram-negative bacteria with antimicrobial compounds by employing widely used computational
techniques, such as molecular docking and molecular dynamics simulations.
[Email] [Google Scholar] [ORCID profile]
|
 Enrico Margiotta.
Ph.D. in Theoretical and Medicinal Chemistry. Expertise in MM and QM-DFT methods for application towards structure-based and ligand-based drug design. Currently Research Scientist at Broad Institute of MIT & Harvard (USA).
[Semantic Scholar]
|